The US Securities and Exchange Commission (SEC) has moved a step closer to approving the New York Stock Exchange’s Rule 452 proposal to eliminate broker discretionary voting in director elections.  This proposal was developed by the Exchange’s Proxy Working Group in 2006. The NYSE has recently re-filed its proposed amendment to Rule 452 and includes […]

Read More

As Swiss pharma giant Novartis squared up to the first of the 2009 European season’s shareholder resolutions, it looks like voting irregularities downstream may be calling the results into question. Novartis are said to be ‘furious’ at the apparent foul ups caused by the overly complicated ‘chain of intermediaries’ which have left some shareholders with […]

Read More